InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Mcgovern Mark e, 董事. Director active across 1 company, notably Esperion Therapeutics, Inc.. Cumulatively, 1 disclosures have been published. History available since 27 May 2021. The latest transaction was filed on 27 May 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mcgovern Mark e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
About Mcgovern Mark e
Mark E. McGovern serves as a Director at Esperion Therapeutics, Inc. In this role, he contributes to the company's strategy and governance. His expertise in the biopharmaceutical sector is an asset to the board.
